Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Medeon Biodesign

Medeon Biodesign
2012 FOUNDED
PUBLIC STATUS
6499 STOCK SYMBOL
2 INVESTMENTS
$2.10 SHARE PRICE (As of Friday Closing)
Description

Medeon Biodesign Inc develops medical device products. It is developing devices for invasive surgeries and for treating diseases including cardiovascular, peripheral vascular, orthopedic, neurosurgery, obesity, gastroenterology, hematology, & nephrology. The company provides products in fields of cardiovascular and laparoscopic.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Stock Exchange
ROCO
Primary Office
  • 116, HouGang Street
  • 7th Floor
  • Taipei, 111-70
  • Taiwan

+886 02 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Medeon Biodesign’s full profile, request a free trial.

Medeon Biodesign Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.89 - $2.89 $140M $2.02 -$0.11 64.4K 66.5M

Medeon Biodesign Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 89,065 113,440 109,155 175,824
Revenue 13,299 22,326 5,405 904
EBITDA (4,909) 8,821 (7,548) (6,439)
Net Income (7,134) 8,506 (8,119) (6,749)
Total Assets 82,411 63,675 55,192 55,284
Total Debt 3,917 1 186 271
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medeon Biodesign Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Medeon Biodesign‘s full profile, request access.

Request full access to PitchBook

Medeon Biodesign Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 31-May-2019 000000000 Therapeutic Devices
Panther Orthopedics 28-Mar-2018 Corporate Therapeutic Devices 000-000 0000 00.0
To view this company’s complete investment and acquisition history, request access »

Medeon Biodesign Executive Team (2)

Name Title Board
Seat
Contact
Info
Yue-Teh Jang Ph.D Founder, Chairman, President & Chief Executive Officer
Shuling Cheng Ph.D Chief Strategy Officer

Medeon Biodesign Board Members (1)

Name Representing Role Since Contact
Info
Yue-Teh Jang Ph.D Medeon Biodesign Founder, Chairman, President & Chief Executive Officer 000 0000